ÂÜÀòÂÒÂ×

Jonca Bull, M.D., serves as consultant focused on drug development and regulatory considerations since May 2019. As a regulatory affairs authority with broad therapeutic expertise, she helps guide the strategic development and implementation of clinical trial protocols.

From 2017-2019, she served as Vice President of Regulatory Consulting within PPD Global Product Development and therapeutic director for Ophthalmology. She is a subject matter expert in advancing clinical trial diversity, bioethical considerations in clinical trials and for patient centricity and patient voice. Prior to joining PPD, Dr. Bull served as assistant commissioner at FDA with a focus on diverse populations and clinical trials; vice president for U.S./North American regulatory policy for Novartis Pharmaceuticals; and director of clinical regulatory policy for Genentech. From 1994 to 2005, Dr. Bull held various senior leadership roles with the FDA across various disease areas and programs. From 1982 to 1994 she cared for patients in a multi-specialty medical/surgical practice in the Washington metro area.

Dr. Bull holds an undergraduate degree from Princeton University, a medical degree from Duke University, and she did residencies in general medicine and ophthalmology at George Washington University Hospital in Washington, D.C., where she served as an assistant clinical professor. She is board certified and a fellow of the American Academy of Ophthalmology.